Effects of Caffeine and Coffee on Resting Metabolic Rate, Comparing Normal Weight Men to Obese Men

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

33 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-10-31

Study Completion Date

2016-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Background. The prevalence of obesity has increased in the last two decades. To maintain body weight energy expenditure (EE) should be equal to energy intake (EI). A low EE predisposes individuals to weight gain and to obesity that can also results from low resting metabolic rate (RMR). Caffeine (Caf) is an active food ingredient and is widely consumed globally, and has an important impact on energy balance. Caf reduces appetite (EI) and increases EE, thus, Caf has a potential role in body weight reduction. Caf causes higher total daily energy expenditure (TDEE) in normal weight (NW) people compared to obese (OW). Moreover Caf is linked to decreased fat oxidation in OW. There are differences between OW and NW in Caf pharmacokinetics, but no differences reported between NW and OW females in its effects on RMR. There is a gender difference in the influence of Caf on metabolism. The investigators are aware of no previous studies which compared the effect of Caf on the RMR of NW and OW men.

Objectives. 1) To compare the effect of Caf and coffee on resting metabolic rate (RMR) values in healthy normal-weight (NW) men and overweight (OW) men. 2) To develop Caf intake frequency questionnaire (in Hebrew)

Hypothesis. RMR values will be higher and respiratory exchange ratio (RER) values will be lower in NW compared to the values measured in OW men.

Methods. 33 men (16 NW and 17 OW) were reported to the laboratory on 4 separate occasions (placebo, Caf tablets, coffee and decaffeinated coffee). During the lab sessions they were undergo complete anthropometric measurements and RMR measured (one of the study conditions) using indirect calorimetry. Additionally, respiratory exchange ratio (RER) which is calculated as the ratio between CO2 production (VCO2) and O2 consumption (VO2) (VCO2/VO2), blood pressure and heart rate (HR) response recorded.

The importance of this study is that the results will contribute to the scientific basis of weight control and health interventions programs (diet and physical activity) in overweight men.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Effect of Coffee on Energy Expenditure and Caffeine Metabolism

NCT06712511

Healthy

RECRUITING NA

Effects of Caffeinated and Decaffeinated Coffee on Body Weight and Glucose Tolerance

NCT00305097

Overweight

COMPLETED NA

Effects of Different Coffee Amounts on Energy Intake, Appetite, Glucose Metabolism and Inflammatory Markers

NCT01495754

Obesity Inflammation

COMPLETED NA

Effect of Coffee Consumption on Appetite Traits in Overweight and Obesity

NCT05774119

Obesity

COMPLETED NA

Caffein Consumption and Response Inhibition

NCT01815203

Eating Behavior Obesity

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Methods. 16 NW and 17 OW men were reported to the laboratory on 4 separate occasions (placebo, Caf tablets, coffee and decaffeinated coffee) each separated by 2-7 days. Before the first meeting they refill caffeine, physical activity and medical questionnaires. The investigators recruited only men who were healthy non-smokers with no comorbidities and the daily caffeine consumption was under 400 mg. Before each meeting participants had to comply guidelines outlined included fasting for 8 hours, avoiding intense physical activity 14 hours and moderate exercise 2 hours before measurements. The meetings conducted in the morning when the first session included anthropometric measurements (weight, height and waist circumference) and body composition measurements using Bioelectrical Impedance Analysis (BIA) and a digital caliper. Each session began with a measuring resting blood pressure and heart rate (Polar telemetric systems), after that participants were given randomly placebo or Caf tablets or coffee or decaffeinated coffee, waiting half an hour and then measuring the RMR and respiratory exchange ratio (RER), for half an hour using indirect calorimetry (canopy system). Then again measured blood pressure and heart rate at rest.

The sample size was calculated for 16 participant in each group, according to an expected change of 3% at RMR values between the groups with the power of 80% and significance of 0.05 . standard deviation (SD).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Asymptomatic Conditions

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Caffeine

Caffeine capsule (200 mg) is taken prior to RMR measurement

Group Type EXPERIMENTAL

Caffeine

Intervention Type DIETARY_SUPPLEMENT

200 mg of caffeine capsule before RMR measurement

Placebo

Intervention Type DIETARY_SUPPLEMENT

Placebo capsule (starch) before RMR measurement

Coffee

Intervention Type OTHER

9 grams of black coffee in boiling water consumed before RMR measurement

Decaffeinated

Intervention Type OTHER

9 grams of decaffeinated black coffee in boiling water consumed before RMR measurement

Placebo

Placebo (starch) capsule is taken prior to RMR measurement

Group Type PLACEBO_COMPARATOR

Caffeine

Intervention Type DIETARY_SUPPLEMENT

200 mg of caffeine capsule before RMR measurement

Placebo

Intervention Type DIETARY_SUPPLEMENT

Placebo capsule (starch) before RMR measurement

Coffee

Intervention Type OTHER

9 grams of black coffee in boiling water consumed before RMR measurement

Decaffeinated

Intervention Type OTHER

9 grams of decaffeinated black coffee in boiling water consumed before RMR measurement

Coffee

Black coffee (9 grams) is consumed prior to RMR measurement

Group Type EXPERIMENTAL

Caffeine

Intervention Type DIETARY_SUPPLEMENT

200 mg of caffeine capsule before RMR measurement

Placebo

Intervention Type DIETARY_SUPPLEMENT

Placebo capsule (starch) before RMR measurement

Coffee

Intervention Type OTHER

9 grams of black coffee in boiling water consumed before RMR measurement

Decaffeinated

Intervention Type OTHER

9 grams of decaffeinated black coffee in boiling water consumed before RMR measurement

Decaffeinated

Decaffeinated Black coffee (9 grams) is consumed prior to RMR measurement

Group Type PLACEBO_COMPARATOR

Caffeine

Intervention Type DIETARY_SUPPLEMENT

200 mg of caffeine capsule before RMR measurement

Placebo

Intervention Type DIETARY_SUPPLEMENT

Placebo capsule (starch) before RMR measurement

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Caffeine

200 mg of caffeine capsule before RMR measurement

Intervention Type DIETARY_SUPPLEMENT

Placebo

Placebo capsule (starch) before RMR measurement

Intervention Type DIETARY_SUPPLEMENT

Coffee

9 grams of black coffee in boiling water consumed before RMR measurement

Intervention Type OTHER

Decaffeinated

9 grams of decaffeinated black coffee in boiling water consumed before RMR measurement

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

33 Healthy men at the age between 20-50 years. 16 normal weight men and 17 obese men.

Exclusion Criteria

1. Hypertension (above 140/90 mmHg)
2. Taking medications for hypertension
3. Heart, liver or kidney problems, diabetes, respiratory problems, hypo/hyper thyroidism.
4. Smoking
5. Men who consume caffeine above 400 mg/day
6. Taking medications or dietary supplements that can affect energy expenditure
7. Elite athletes (competitive sport)
8. Night Eating

Minimum Eligible Age

20 Years

Maximum Eligible Age

50 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes